Spots Global Cancer Trial Database for Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers
Official Title: Early Salpingectomy (Tubectomy) With Delayed Oophorectomy to Improve Quality of Life as Alternative for Risk Reducing Salpingo-oophorectomy in BRCA1/2 Gene Mutation Carriers
Study ID: NCT02321228
Study Description
Brief Summary: The purpose of this study is to determine whether an innovative preventive strategy, consisting of early salpingectomy upon completion of childbearing with delayed oophorectomy beyond current guideline age, improves menopause-related quality of life without significantly increasing ovarian cancer incidence in comparison to current standard salpingo-oophorectomy in female BRCA1/2 mutation carriers.
Detailed Description: Eligible women will choose for the innovative or standard risk-reducing option themselves.
Eligibility
Minimum Age: 25 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Maastricht University Medical Center, Maastricht, Limburg, Netherlands
Catharina Hospital, Eindhoven, Noord-Brabant, Netherlands
Elisabeth-TweeSteden Hospital, Tilburg, Noord-Brabant, Netherlands
Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands
Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
Academic Medical Center, Amsterdam, , Netherlands
VU University Medical center, Amsterdam, , Netherlands
University Medical Center Groningen, Groningen, , Netherlands
Medical Center, Leeuwarden, , Netherlands
Radboudumc, Nijmegen, , Netherlands
University Medical Center Utrecht, Utrecht, , Netherlands
Maxima Medical Center, Veldhoven, , Netherlands
Contact Details
Name: Joanne A de Hullu, MD, PhD
Affiliation: University Medical Center Nijmegen
Role: PRINCIPAL_INVESTIGATOR
Name: Rosella PM Hermens, PhD
Affiliation: Scientific Institute for Quality of Healtcare, UMCNijmegen
Role: PRINCIPAL_INVESTIGATOR
Name: Nicoline Hoogerbrugge, MD, PhD
Affiliation: University Medical Center Nijmegen
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
